PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder- Functional Health and Well-Being Efficacy Results from a Phase III Clinical Trial
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.497
https://www.valueinhealthjournal.com/article/S1098-3015(12)00562-1/fulltext
Title :
PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder- Functional Health and Well-Being Efficacy Results from a Phase III Clinical Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00562-1&doi=10.1016/j.jval.2012.03.497
First page :
A91
Section Title :
Mental Health
Open access? :
No
Section Order :
1292